On Friday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.29 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.09. The stock opened at $60 and ...
Catalent, Inc. (CTLT) said, following the closing of transaction, as a private company under Novo Holdings' ownership, Catalent will ...
Investors might want to bet on Catalent (CTLT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
On Monday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.65 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.45. The stock opened at $60.5 and ...
Production of Johnson & Johnson’s (JNJ.N) COVID-19 vaccine at a U.S. manufacturing plant was halted by the U.S. Food and Drug Administration while the agency ...
Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have received an average recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Eight ...
1 Day CTLT -0.63% DJIA 0.79% S&P 500 0.47% Health Care/Life Sciences -0.97% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback